Antineutrophil Cytoplasmic Antibody-Associated Vasculitis and COVID-19: The Clinical Course and Prognosis of 15 Patients From a Tertiary Care Center.

İnce, Burak; Bektaş, Murat; Koca, Nevzat; Ağargün, Besim; Zarali, Sibel; Güzey, Damla; Durak, Görkem; Yalçinkaya, Yasemin; Artim-Esen, Bahar; Gül, Ahmet; İnanç, Murat

doi:10.1097/rhu.0000000000001855

Antineutrophil Cytoplasmic Antibody-Associated Vasculitis and COVID-19: The Clinical Course and Prognosis of 15 Patients From a Tertiary Care Center.

İnce B., Bektaş M., Koca N., Ağargün B. F., Zarali S., Güzey D. Y., ...Daha Fazla

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, cilt.28, sa.6, ss.300-304, 2022 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 28 Sayı: 6
Basım Tarihi: 2022
Doi Numarası: 10.1097/rhu.0000000000001855
Dergi Adı: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE
Sayfa Sayıları: ss.300-304
İstanbul Üniversitesi Adresli: Evet

Özet

Objective: The aim of this study was to evaluate incidence rates, prognoses, and disease-related factors associated with poor outcomes in patients with antineutrophil cytoplasmic antibody-associated vasculitis (AAV) who had coronavirus disease (COVID-19).